At the Military Medical University (Photo: VNA)

Twenty volunteers received the second shots of Nanocovax - a Vietnam-developed COVID-19 vaccine at the Military Medical University on January 20.

Among them, three people, who had beeninjected a dose on December 26, 2020, were given a dose of 50mcg and theremainders got a dose of 25 mcg. All of the volunteers are now in stableconditions.

Vietnam has so far gone through morethan half of the first stage of clinical vaccine trials.

Associate Prof. Ho Anh Son, DeputyDirector of the Military Medical University’s Institute of Biomedicine andPharmacy,said the test results 7,14 and 28 days after the injection showed thatthe vaccine is capable of producing immunity and ensuring safety.

Out of over 500 applicants for thevaccine trial, more than 200 underwent health check-ups, of whom 51 people areeligible for the first stage.

The second stage, starting fromFebruary, is expected to conduct trials on 400-600 people aged between 12-17.

The Ho Chi Minh City Pasteur Institute andthe National Institute of Hygiene and Epidemiology will also join in thevaccine research.

The third stage, scheduled for August,will see trials on 10,000 - 30,000.

If successful, Vietnam will begin massproduction of the COVID-19 vaccine in early 2022./. VNA

Human trials of third homegrown COVID-19 vaccine to begin in March

A third COVID-19 vaccine developed by Vietnam is scheduled to be tested on humans at the end of March, the Ministry of Health said on January 19.